All In Biotech

Drug Trial Radar · NCT06378268

PPOS vs GnRH Antagonist in Ovarian Stimulation (ProGanOS Study)

Effectiveness of Progestin-Primed Ovarian Stimulation Versus GnRH Antagonist Protocol for Ovarian Stimulation in IVF: a Randomized Clinical Trial

Last checked: Nov 19, 2026Latest source record: Mar 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingRandomized with 626 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

626

Planned (sponsor's estimate)

Start

Apr 24, 2024

Primary completion

Jun 30, 2026

Study completion Sep 30, 2026

Sponsor

Lead sponsor
Mỹ Đức HospitalAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Apr 22, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
Female only, from 18 years, up to 40 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This non-inferiority randomized controlled trial will be conducted at My Duc Hospital, Ho Chi Minh City, Vietnam. This study compares the effectiveness of Progestin-Primed Ovarian stimulation versus GnRH protocol for ovarian stimulation in IVF treatment. Participants will be randomly assigned in a 1:1 ratio to receive Progestins or GnRH antagonists.

Conditions

  • Progestins Primed Ovarian Stimulation

Interventions

  • Dydrogesterone 10 mgDrug

    Dydrogesterone 10mg orally 2 times daily, starting on the day of gonadotropin injection to the oocyte maturation trigger night.

  • Cetrorelix 0.25 mgDrug

    Cetrorelix 0.25mg is injected subcutaneously once a day. It is given from day 5 or day 6 of stimulation by the oocyte maturation trigger day.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Ongoing pregnancyTime frame: At 10 weeks after embryo(s) placement

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • My Duc Hospital

    Ho Chi Minh City, Ho Chi Minh City, Vietnam

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.